Skip to main content
Top
Published in: Journal of Neurology 12/2021

Open Access 01-12-2021 | Portal Vein Thrombosis | Letter to the Editors

Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis

Authors: Tilmann Graf, Thomas Thiele, Randolf Klingebiel, Andreas Greinacher, Wolf-Rüdiger Schäbitz, Isabell Greeve

Published in: Journal of Neurology | Issue 12/2021

Login to get access

Excerpt

Dear Sirs, …
Literature
Metadata
Title
Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis
Authors
Tilmann Graf
Thomas Thiele
Randolf Klingebiel
Andreas Greinacher
Wolf-Rüdiger Schäbitz
Isabell Greeve
Publication date
01-12-2021
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 12/2021
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-021-10599-2

Other articles of this Issue 12/2021

Journal of Neurology 12/2021 Go to the issue

Pioneers in Neurology

Theodor Schwann (1810–1882)

Pioneers in Neurology

Johannes Schmiedt (1623–1690)